These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
These kits are intended for in vitro diagnostic use.
These kits are for research use only and are not intended to be used for diagnostic procedures.
Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
Biological risk products.
Storage between 2 and 8 ° C.
Reactive in liquid form.
Reactive in lyophilized form.
Reactive in frozen form.
Stability after opening at 2-8 ° C.
Products that can be refrozen.
Stability 12 months after refreezing at -20 ° C.
Consumable for T-TAS® 01
CaCTI solution (Calcium Corn Trypsin inhibitor) for measurement with the AR chip.
Number of tests
1 x 0.4 mL
1 x 20
The Safety Data Sheets and Notices are accessible to our registered customers.
A complex web of biochemical and physical reactions between platelets and clotting factors at the site of vascular injury is required to achieve hemostasis.
Under flow conditions, platelet activation and coagulation processes are dynamically intertwined with each other affected by platelets, coagulation factors and their various inhibitors and activators.
CTI works to inhibit the intrinsic signaling pathway (contact pathway) of coagulation by reversibly binding to FXIIa.
Calcium ions are used to recalcify citrated blood, suppressing the inhibition of several coagulation factors (FIXa, FXa) allowing the extrinsic pathway to initiate its own activation.